<DOC>
	<DOCNO>NCT01651273</DOCNO>
	<brief_summary>The purpose study evaluate safety BMS-852927 28 day dose patient high cholesterol .</brief_summary>
	<brief_title>A Safety Study BMS-852927 Subjects With Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Men woman , age ≥18 ≤75 Body mass index ( BMI ) ≤ 40 kg/m2 Primary hypercholesterolemia stable daily dose statin ≥ 6 week Serum triglyceride level screen &lt; 400mg/dL ( &lt; 4.52 mmol/L ) Any significant acute medical illness , significant cardiovascular history Current history hepatic hepatobiliary disease Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECG clinical laboratory determination beyond consistent target population</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>